Sunita Nair
Senior Director, Systematic Literature Reviews and Meta-analysis
Sunita Nair is a Practice Head at Clarivate, leading our Systematic Literature Reviews and Meta- analysis Centre of Excellence. Sunita is a business leader with 25 years experience and provides leadership to our highly skilled team of systematic reviewers and meta-analysis experts. She has supported several US FDA and HTA submissions. She has formerly worked in tertiary hospitals and multinational pharmaceutical companies (Sanofi, Novartis) in India. She has vast experience in establishing businesses, and managing teams providing services in HEOR, medical writing and clinical development. Her core areas of interest include cardiovascular research, HEOR, knowledge management, market access, market research, medical communications, molecular diagnostics, and scientific writing.
Sunita is a regular speaker at scientific conferences, on the review panel of several journals, and a National Executive Committee member of the ISPOR India chapter.
Sunita has a PhD in Applied Biology (Molecular Biology) and a master’s degree in Microbiology from the University of Mumbai, and a Post-Graduate Diploma in Global Health Policy from the London School of Hygiene and Tropical Medicine. She is also trained in Knowledge Management, carried out at the Indian Institute of Management.
Latest news
Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude
Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows LONDON, U.K, March 10, 2026 Clarivate Plc…
National Research Council of Italy Joins Early Adopter Cohort for Web of Science Research Intelligence
London, U.K. March 9, 2026: Consiglio Nazionale delle Ricerche (CNR), the National Research Council of Italy, has joined the early adopter program for Web of Science Research Intelligence from Clarivate,…
Clarivate Library Innovation Awards Reveal the 2026 Finalists
An independent judging panel selected finalists who demonstrated exceptional creativity, innovation and impact London, U.K. March 5, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced…
